Beijing SL Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing SL Pharmaceutical Co Ltd with three other
companies in this sector in China:
Staidson (Beijing) Biopharmaceuticals Co Ltd
sales of 1.25 billion Chinese Renmimbi [US$180.83 million]
of which 100%
was Pharmaceutical manufacturing),
Jinyu Bio-Technology Co Ltd
(1.25 billion Chinese Renmimbi [US$180.45 million]
of which 97%
was Bio-Pharmaecutical), and
Walvax Biotechnology Company Limited
(1.01 billion Chinese Renmimbi [US$145.69 million]
of which 58%
was Vaccine Product Subcontract).
Beijing SL Pharmaceutical Co Ltd reported sales of 1.16 billion Chinese Renmimbi (US$167.59 million)
December of 2015.
decrease of 6.9%
versus 2014, when the company's sales were 1.24 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 24.2% decline
in Other Operating, from 36.00 million Chinese Renmimbi to 27.28 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceuticals Industry (down 6.4% to 1.13 billion Chinese Renmimbi)